Stakeholders' perspectives about challenges, strategies and outcomes of importance associated with adherence to appropriate polypharmacy in older patients - A qualitative study.

Hanadi A Al Shaker, Heather E Barry, Carmel M Hughes
Author Information
  1. Hanadi A Al Shaker: School of Pharmacy, Queen's University Belfast, Belfast, United Kingdom.
  2. Heather E Barry: School of Pharmacy, Queen's University Belfast, Belfast, United Kingdom.
  3. Carmel M Hughes: School of Pharmacy, Queen's University Belfast, Belfast, United Kingdom.

Abstract

Background: Older patients experience challenges when taking polypharmacy. Studies have applied different interventions to improve adherence to polypharmacy. However, inconsistencies in outcomes have impeded the synthesis of evidence. To generate high-quality studies and selectively report outcomes, a Core Outcome Set (COS) is advocated.
Objectives: This study explored stakeholders' perspectives about the challenges older patients face when taking polypharmacy, strategies to overcome each challenge, and outcomes of importance that may contribute to COS development.
Methods: Semi-structured interviews were undertaken with academics, healthcare professionals, and public participants. A series of open-ended questions investigated challenges with adherence to polypharmacy in older patients and strategies to overcome these challenges. A list of outcomes ( = 7) compiled from previous studies associated with adherence to polypharmacy was presented to participants for their views. Content analysis was conducted to identify key themes and outcomes proposed by participants.
Results: Participants suggested 11 multidimensional healthcare system-related, medication-related, patient-related, and socioeconomic-related challenges and 16 educational and behavioural strategies associated with adherence to polypharmacy in older patients. Participants agreed with the importance of the seven outcomes presented and suggested a further six outcomes they deemed to be important for use in trials aimed at improving adherence to appropriate polypharmacy in older patients.
Conclusions: Adherence to polypharmacy was deemed challenging, requiring supportive interventions. A list of 13 outcomes in the context of adherence to appropriate polypharmacy in older patients was identified to inform a future study that will develop a COS for clinical trials targeting interventions to improve adherence to appropriate polypharmacy in older patients.

Keywords

References

  1. PLoS One. 2019 Mar 28;14(3):e0214191 [PMID: 30921379]
  2. Patient Prefer Adherence. 2022 Jun 30;16:1581-1594 [PMID: 35795010]
  3. Health Serv Res. 2016 Aug;51(4):1467-88 [PMID: 26800220]
  4. Health Expect. 2018 Feb;21(1):138-148 [PMID: 28766816]
  5. J Behav Med. 2016 Dec;39(6):935-946 [PMID: 27515801]
  6. Drugs Aging. 2016 Apr;33(4):249-66 [PMID: 26915076]
  7. Clin Nurs Res. 2022 Mar;31(3):426-434 [PMID: 34287084]
  8. BMJ Support Palliat Care. 2022 Dec;12(e6):e740-e743 [PMID: 32788273]
  9. Clin Geriatr Med. 2012 May;28(2):287-300 [PMID: 22500544]
  10. Adv Ther. 2016 Oct;33(10):1740-1754 [PMID: 27503082]
  11. J Psychosom Res. 2018 Dec;115:110-116 [PMID: 30470309]
  12. Oman Med J. 2011 May;26(3):155-9 [PMID: 22043406]
  13. Br J Clin Pharmacol. 2012 May;73(5):691-705 [PMID: 22486599]
  14. Saudi Pharm J. 2023 May;31(5):678-686 [PMID: 37181136]
  15. Risk Manag Healthc Policy. 2014 Feb 20;7:35-44 [PMID: 24591853]
  16. Expert Opin Drug Saf. 2014 Jan;13(1):57-65 [PMID: 24073682]
  17. J Invest Dermatol. 2018 Apr;138(4):785-794 [PMID: 29183731]
  18. Fam Med Community Health. 2019 Mar 8;7(2):e000057 [PMID: 32148704]
  19. Health Qual Life Outcomes. 2020 Jan 7;18(1):6 [PMID: 31910879]
  20. PLoS One. 2013 Dec 02;8(12):e80633 [PMID: 24312488]
  21. J Appl Gerontol. 2019 Jun;38(6):866-883 [PMID: 28645225]
  22. J Rheumatol. 2021 Sep;48(9):1480-1487 [PMID: 33993113]
  23. Nutr Metab Cardiovasc Dis. 2009 Jan;19(1):45-53 [PMID: 18450436]
  24. Cochrane Database Syst Rev. 2023 Oct 11;10:CD008165 [PMID: 37818791]
  25. Am J Health Syst Pharm. 2003 Jun 1;60(11):1123-9 [PMID: 12816022]
  26. Drug Saf. 2016 Feb;39(2):109-16 [PMID: 26692396]
  27. Drugs Aging. 2004;21(12):793-811 [PMID: 15382959]
  28. J Am Geriatr Soc. 2004 Sep;52(9):1487-94 [PMID: 15341550]
  29. Perspect Public Health. 2015 Sep;135(5):243-50 [PMID: 26187638]
  30. BMJ Open. 2018 Jan 23;8(1):e015332 [PMID: 29362241]
  31. Am J Geriatr Pharmacother. 2010 Oct;8(5):428-40 [PMID: 21335296]
  32. Mt Sinai J Med. 2011 Nov-Dec;78(6):813-9 [PMID: 22069204]
  33. Pilot Feasibility Stud. 2021 Jan 7;7(1):18 [PMID: 33413650]
  34. BMC Geriatr. 2017 Oct 10;17(1):230 [PMID: 29017448]
  35. Int J Qual Health Care. 2007 Dec;19(6):349-57 [PMID: 17872937]
  36. Drugs Aging. 2001;18(1):63-77 [PMID: 11232739]
  37. Fam Pract. 2007 Apr;24(2):189-200 [PMID: 17272285]
  38. Cochrane Database Syst Rev. 2020 May 8;5:CD012419 [PMID: 32383493]
  39. Br J Clin Pharmacol. 2018 Aug;84(8):1789-1797 [PMID: 29790202]
  40. PLoS One. 2017 Feb 6;12(2):e0171320 [PMID: 28166266]
  41. Int J Clin Pharm. 2014 Oct;36(5):873-81 [PMID: 25037952]
  42. Int J Alzheimers Dis. 2016;2016:9213968 [PMID: 28083154]
  43. Cochrane Database Syst Rev. 2014 Nov 20;(11):CD000011 [PMID: 25412402]
  44. Medicine (Baltimore). 2019 Dec;98(49):e17825 [PMID: 31804305]
  45. BMJ Open. 2018 Jan 21;8(1):e016982 [PMID: 29358417]
  46. Trials. 2017 Jun 20;18(Suppl 3):280 [PMID: 28681707]
  47. Qual Health Res. 2017 Jul;27(8):1215-1224 [PMID: 28682739]
  48. Aging Med (Milton). 2020 Nov 10;4(1):35-41 [PMID: 33738378]
  49. J Affect Disord. 2013 Jul;149(1-3):247-52 [PMID: 23489403]
  50. J Clin Epidemiol. 2018 Apr;96:84-92 [PMID: 29288712]
  51. Biomed Res Int. 2015;2015:217047 [PMID: 26539470]
  52. Value Health. 2019 Feb;22(2):139-156 [PMID: 30711058]
  53. Eur J Clin Pharmacol. 2017 Nov;73(11):1475-1489 [PMID: 28779460]
  54. Sci Rep. 2020 Nov 3;10(1):18964 [PMID: 33144598]
  55. Curr Opin Anaesthesiol. 2020 Feb;33(1):109-113 [PMID: 31789903]
  56. BMC Fam Pract. 2016 Aug 11;17(1):109 [PMID: 27515854]
  57. Prev Chronic Dis. 2022 Aug 18;19:E50 [PMID: 35980834]
  58. Eur J Clin Pharmacol. 2014 Jan;70(1):1-11 [PMID: 24019054]

Word Cloud

Created with Highcharts 10.0.0polypharmacyoutcomespatientsadherenceolderchallengesstrategiesappropriateinterventionsCOSstudyimportanceparticipantsassociatedOldertakingimprovestudiesperspectivesovercomehealthcarelistpresentedParticipantssuggesteddeemedtrialsAdherenceBackground:experienceStudiesapplieddifferentHoweverinconsistenciesimpededsynthesisevidencegeneratehigh-qualityselectivelyreportCoreOutcomeSetadvocatedObjectives:exploredstakeholders'facechallengemaycontributedevelopmentMethods:Semi-structuredinterviewsundertakenacademicsprofessionalspublicseriesopen-endedquestionsinvestigated = 7compiledpreviousviewsContentanalysisconductedidentifykeythemesproposedResults:11multidimensionalsystem-relatedmedication-relatedpatient-relatedsocioeconomic-related16educationalbehaviouralagreedsevensiximportantuseaimedimprovingConclusions:challengingrequiringsupportive13contextidentifiedinformfuturewilldevelopclinicaltargetingStakeholders'-qualitativeInterviewpeopleOutcomesPolypharmacyQualitativeresearch

Similar Articles

Cited By

No available data.